Volume 16, Number 4—April 2010
CME ACTIVITY - Research
Community-associated Methicillin-Resistant Staphylococcus aureus Strains in Pediatric Intensive Care Unit1
Aaron M. Milstone
, Karen C. Carroll, Tracy Ross, K. Alexander Shangraw, and Trish M. Perl
, Karen C. Carroll, Tracy Ross, K. Alexander Shangraw, and Trish M. Perl
Table 4
Characteristics of patients who acquired MRSA colonization in the PICU, The Johns Hopkins University Hospital, Baltimore, MD, USA, March 2007–2008*
| Patient no. | Age, y | Culture type | Days in PICU before MRSA acquisition | Strain type | Clinical service |
|---|---|---|---|---|---|
| 1 | 7.0 | Clin | 19 | A | Surg |
| 2 | 4.5 | Surv | 7 | A | Med |
| 3 | 11.2 | Surv | 5 | B | Surg |
| 4 | 2.5 | Surv | 9 | USA300 | Surg |
| 5 | 1.2 | Surv | 5 | USA300 | Surg |
| 6 | 9.9 | Surv | 24 | USA300 | Surg |
| 7 | 3.8 | Clin | 5 | USA300 | Surg |
| 8 | 7.5 | Surv | 5 | Unknown | Med |
*MRSA, methicillin-resistant Staphylococcus aureus; PICU, pediatric intensive care unit; Clin, clinical; Surg, surgical; Surv, surveillance; Med, medical.
1These data were presented in part at the Annual Scientific Meeting of the Society of Healthcare Epidemiology of America, Orlando, Florida, USA, April 2008.
Page created: December 23, 2010
Page updated: December 23, 2010
Page reviewed: December 23, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.